6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Clinical Addiction Research and Education (CARE)
Medication instruction is the arrangement of data, assets, and abilities applicable to experiencing a daily reality such that psychoactive substances are broadly accessible and usually utilized for an assortment of both clinical and non-clinical purposes, some of which may prompt damages, for example, glut, injury, irresistible illness, (for example, HIV or hepatitis C), or enslavement.
Habit brain science generally includes the clinical brain research and strange brain research teaches and encourages the use of data acquired from research with an end goal to properly analyse, assess, treat, and backing customers managing without dependence. All through the treatment interaction compulsion therapists energize practices that form health and passionate flexibility to their physical, mental and enthusiastic issues.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States